Cargando…

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty

OBJECTIVE: The study aimed to assess the effect of gonadotropin-releasing hormone (GnRH) agonist therapy on body mass index (BMI) and growth in girls diagnosed with idiopathic central precocious puberty (CPP). MATERIALS AND METHODS: Hospital records of 32 girls with idiopathic CPP who have been rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anık, Ahmet, Çatlı, Gönül, Abacı, Ayhan, Böber, Ece
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319268/ https://www.ncbi.nlm.nih.gov/pubmed/25729690 http://dx.doi.org/10.4103/2230-8210.131770

Ejemplares similares

Acceleration of Puberty During Growth Hormone Therapy in a Child with Septo-Optic Dysplasia
por: Çatlı, Gönül, et al.
Publicado: (2014)

Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
por: Chen, Tao, et al.
Publicado: (2020)

Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018)

Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
por: Chung, Lindsey Yoojin, et al.
Publicado: (2020)

The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty
por: Kim, Sung Woo, et al.
Publicado: (2017)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017)

Epidemiology, Classification and Management of Undescended Testes: Does Medication Have Value in its Treatment?
por: Abacı, Ayhan, et al.
Publicado: (2013)

46,XX Male Disorder of Sexual Development: A Case Report
por: Anık, Ahmet, et al.
Publicado: (2013)

A Case of Central Precocious Puberty Due to Concomitant Hypothalamic Hamartoma and Juvenile Pilocytic Astrocytoma
por: Çatlı, Gönül, et al.
Publicado: (2014)

The Role of Thyrotropin-Releasing Hormone Stimulation Test in Management of Hyperthyrotropinemia in Infants
por: Altıncık, Ayça, et al.
Publicado: (2015)

Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty
por: Yu, Hong-kui, et al.
Publicado: (2019)

Has the Frequency of Precocious Puberty and Rapidly Progressive Early Puberty Increased in Girls During the COVID-19 Pandemic?
por: Yüksek Acinikli, Kübra, et al.
Publicado: (2022)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
por: Lee, Seung Jae, et al.
Publicado: (2012)

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014)

Acute Vitamin D Intoxication Possibly Due to Faulty Production of a Multivitamin Preparation
por: Anık, Ahmet, et al.
Publicado: (2013)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015)

Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
por: Kwon, Ahreum
Publicado: (2023)

The Effect of L-Thyroxine Treatment on Hypothyroid Symptom Scores and Lipid Profile in Children with Subclinical Hypothyroidism
por: Çatlı, Gönül, et al.
Publicado: (2014)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist
por: Alessandri, Sandra B, et al.
Publicado: (2012)

The Influence of Gonadotropin-Releasing Hormone Agonist Treatment on Thyroid Function Tests in Children with Central Idiopathic Precocious Puberty
por: Naderi, Fariba, et al.
Publicado: (2019)

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2021)

Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2023)

Commentary on "Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty"
por: Cheon, Chong Kun
Publicado: (2021)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
por: Jeon, Min Jin, et al.
Publicado: (2021)

The genes associated with gonadotropin-releasing hormone-dependent precocious puberty
por: Hwang, Jin Soon
Publicado: (2012)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Sifaki, Loukia, et al.
Publicado: (2019)

Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
por: Park, Jina, et al.
Publicado: (2017)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty
por: Lee, Hae Sang, et al.
Publicado: (2016)

Factors to Predict Positive Results of Gonadotropin Releasing Hormone Stimulation Test in Girls with Suspected Precocious Puberty
por: Nam, Hyo-Kyoung, et al.
Publicado: (2012)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
por: Baek, Joon-Woo, et al.
Publicado: (2014)

Dual effects of a gonadotropin-releasing hormone agonist on an adolescent girl with pelvic congestion syndrome and precocious puberty: a case report
por: Yu, Jwo-Huey, et al.
Publicado: (2020)

Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qi1rqkijav4uah1d7n2uc7v7e1